Daniel Neureiter
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Histone Deacetylase Inhibitors Research 22
- Epigenetics and DNA Methylation 15
- Oncology 59
- Pancreatic and Hepatic Oncology Research 11
- Cancer Cells and Metastasis 9
- Co-authors
- Tobias Kiesslich (78 shared papers)Thomas Aigner (14 shared papers)Matthias Ocker (49 shared papers)E. Klieser (48 shared papers)Pietro Di Fazio (25 shared papers)Martin Pichler (25 shared papers)Christian Mayr (43 shared papers)Eckhart G. Hahn (13 shared papers)
- Journals
- International Journal of Molecular Sciences (9 papers)Cancers (8 papers)Oncotarget (6 papers)PLoS ONE (5 papers)Cells (4 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Daniel Neureiter
237 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 143
- Cancer Research 773
- Oncology 1.2k
- Rheumatology 673
- Hepatology 256
- Pathology and Forensic Medicine 541
Countries citing papers authored by Daniel Neureiter
This map shows the geographic impact of Daniel Neureiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Neureiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Neureiter more than expected).
Fields of papers citing papers by Daniel Neureiter
This network shows the impact of papers produced by Daniel Neureiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Neureiter. The network helps show where Daniel Neureiter may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Neureiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 243 | |
| 2 | 2017 | 158 | |
| 3 | Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. | 2003 | 158 |
| 4 | 2005 | 123 | |
| 5 | 2004 | 121 | |
| 6 | 2015 | 120 | |
| 7 | 2001 | 117 | |
| 8 | 2006 | 114 | |
| 9 | 1997 | 113 | |
| 10 | Subtyping of osteoarthritic synoviopathy. | 2003 | 110 |
| 11 | 2011 | 103 | |
| 12 | 2008 | 87 | |
| 13 | 2012 | 87 | |
| 14 | 2008 | 85 | |
| 15 | 1998 | 78 | |
| 16 | 2011 | 76 | |
| 17 | 2014 | 76 | |
| 18 | 2012 | 73 | |
| 19 | 2015 | 68 | |
| 20 | 2006 | 67 |
About Daniel Neureiter
Daniel Neureiter is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 246 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Histone Deacetylase Inhibitors Research (22 papers), Epigenetics and DNA Methylation (15 papers), Chronic Lymphocytic Leukemia Research (14 papers), Gastric Cancer Management and Outcomes (11 papers), Pancreatic and Hepatic Oncology Research (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Cancer Cells and Metastasis (9 papers). The work is most often cited by research in Cancer Research (773 citations), Oncology (1.2k citations), Rheumatology (673 citations), Hepatology (256 citations) and Pathology and Forensic Medicine (541 citations). Daniel Neureiter has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Tobias Kiesslich, Thomas Aigner, Matthias Ocker, E. Klieser, Pietro Di Fazio, Martin Pichler, Christian Mayr, Eckhart G. Hahn, Thomas Kirchner and Beate Alinger. Their work appears in journals such as International Journal of Molecular Sciences, Cancers, Oncotarget, PLoS ONE and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.